AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
This article explains why benchmark returns can differ from index returns and what this means for investors evaluating results.
26,521 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Three crypto wallets booked $24.25 million in World Cup bets before routing proceeds to one Binance address, triggeri...
A growing trend shows about one-third of workers cash out their 401(K) during job changes, undermining retirement pro...
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A security advisory from Ethereum L2 Taiko warns users to pull funds from Taiko-linked bridges after a state verifica...
Chainlink announces a landmark cross-border banking pact linking European and Korean lenders to test instant FX settl...
A renewed push to replenish and expand U.S. missile arsenals is set to lift production and backlog across defense sup...
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
Pi Network announces a major network community update ahead of Pi2Day, inviting creators and developers to join AI-po...
The FIFA World Cup is fueling a new wave of activity in prediction markets. Kalshi is riding that momentum, turning t...
HYPE and XRP ETFs drew record inflows even as SOL and BTC funds faced net losses, signaling a split in crypto ETF dem...
CoreWeave stock moves in a volatile path as a growing backlog and AI partnerships underpin a potential upside. This a...